Albertson; Tina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Albertson; Tina.The latest application filed is for "methods for treatment using adoptive cell therapy".

Company Profile

7.3.13

Albertson; Tina - Seattle WA
Albertson; Tina - Bothell WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Articles of manufacture and methods for treatment using adoptive cell therapy Grant 11,413,310 - Albertson , et al. August 16, 2	2022-08-16
Detection and treatment of CD30.sup.+ cancers Grant 11,366,118 - Albertson , et al. June 21, 2	2022-06-21
Methods For Treatment Using Adoptive Cell Therapy App 20220088070 - ALBERTSON; Tina ; et al.	2022-03-24
Methods For Dosing And Treatment Of B Cell Malignancies In Adoptive Cell Therapy App 20220031746 - GILLENWATER; Heidi ; et al.	2022-02-03
Methods Of Dosing Engineered T Cells For The Treatment Of B Cell Malignancies App 20220008465 - TREDE; Nikolaus Sebastian ; et al.	2022-01-13
Methods For Dosing And For Modulation Of Genetically Engineered Cells App 20210198372 - ALBERTSON; Tina ; et al.	2021-07-01
Methods Associated With Tumor Burden For Assessing Response To A Cell Therapy App 20200352998 - ALBERTSON; Tina ; et al.	2020-11-12
Articles Of Manufacture And Methods For Treatment Using Adoptive Cell Therapy App 20200147136 - ALBERTSON; Tina ; et al.	2020-05-14
Articles Of Manufacture And Methods Related To Toxicity Associated With Cell Therapy App 20200110077 - YEE; Nathan ; et al.	2020-04-09
Detection And Treatment Of Cd30+ Cancers App 20200110091 - Albertson; Tina ; et al.	2020-04-09
Methods For Determining Car-t Cells Dosing App 20200078400 - LI; He ; et al.	2020-03-12
Methods For Modulation Of Car-t Cells App 20190358262 - ALBERTSON; Tina	2019-11-28
Methods For Adaptive Design Of A Treatment Regimen And Related Treatments App 20190355459 - LI; He ; et al.	2019-11-21
Detection and treatment of CD30.sup.+ cancers Grant 10,444,241 - Albertson , et al. Oc	2019-10-15
Optimal Dosing Of A Cd19-antibody Drug Conjugate App 20170182178 - ZHAO; Baiteng ; et al.	2017-06-29
Detection And Treatment Of Cd30+ Cancers App 20140377286 - Albertson; Tina ; et al.	2014-12-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.